In the past few years, our laboratory has established several novel large animal models of acute and chronic heart failure that represents the clinical phenotype. Representative models are described in the “Animal models” page in our website. As heart tissue is very difficult to obtain from patients, cardiac samples from large animal models are an extremely useful source to evaluate the molecular alterations in a clinically relevant condition. Controlled model creation enables isolation of pathways that are truly involved in heart failure pathophysiology, in comparison to the variability of human tissue due to influences from other diseases including diabetes, renal dysfunction, etc. In the last few years, we have characterized physiological alterations in detail in our unique heart failure models, and further analyses in the molecular pathways will likely lead to novel findings in the coming years.

These animal models are also useful for evaluating the therapeutic efficacy of novel approaches including gene, cell, and small molecule therapies. We have validated several novel gene therapy approaches in clinically relevant heart failure animal models and some of these positive results are expected to be translated into clinical trials in the near future.

In addition, our lab uses the animal models to examine the impact of device-based therapies including left ventricular assist devices and temperature controlling devices.  We have reported how percutaneous left ventricular assist devices alter coronary and left ventricular physiology in different disease settings. Further, we demonstrated that mechanical unloading not only provide beneficial effects on the left ventricle, but also on the left atrium. Multiple studies are underway in our lab to better characterize physiological effects of acute left ventricular unloading and to use it as a therapeutic approach.

As shown in above Figure, we stand at the intersection of various topics associated with cardiovascular research with our main street as clinical translation of new therapeutic approaches.